MRI and MRI-directed biopsies for the diagnosis of prostate cancer

Mark Emberton

The utilization of MRI for the diagnosis of prostate cancer in men at risk is relatively new. In this interview, filmed at the 2018 Genitourinary Cancers Symposium, in San Francisco, CA, Mark Emberton, MD, FRCS, of University College London, London, UK, explains why the use of MRI is important for the diagnosis and treatment of prostate cancer. Prof. Emberton also explains the problems that can arise from not determining tumor location and volume at diagnosis.

Share this video  
Similar topics
Related videos
0:53
Expanding the clinical trial portfolio for lung cancer
Matthew Hatton
2:37
Anti-HER2 strategies in breast cancer: the ALTTO trial
Matteo Lambertini
2:31
An MRI-based approach to prostate cancer diagnosis: a urologist’s stance in the debate
Mark Emberton
1:11
Will diffusion-weighted MRI replace PET-CT in lung cancer?
Katsuo Usuda
2:57
Addressing the issues faced in the ProtecT trial for patients with localized prostate cancer
Freddie Hamdy
Genitourinary Cancer, Prostate Cancer
GU Cancers 2018
Interview
8th February 2018
More from Mark Emberton
Challenges for prostate cancer: overdiagnosis and unnecessary treatment
Is it possible to destroy the cancer while preserving the prostate?
Is delayed diagnosis in the UK to blame for poorer cancer outcomes?
VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJOncology is intended for healthcare professionals